Ascent Biomedical Ventures II, L.P. 4
4 · Motus GI Holdings, Inc. · Filed Feb 21, 2018
Insider Transaction Report
Form 4
Ascent Biomedical Ventures II, L.P.
10% Owner
Transactions
- Conversion
Common Stock, par value $0.0001 per share
2018-02-16+144,352→ 1,591,481 total - Conversion
Series A Convertible Preferred Stock
2018-02-16−144,352→ 0 totalExercise: $0.00→ Common Stock (144,352 underlying) - Other
Warrant (right to buy)
2018-02-16+159,149→ 159,149 totalExercise: $5.00From: 2018-08-15Exp: 2023-02-16→ Common Stock (159,149 underlying)
Footnotes (2)
- [F1]Each share of Series A Convertible Preferred Stock is immediately convertible, at the option of the Reporting Person, into one share of common stock, par value $0.0001 per share (the "Common Stock"), of Motus GI Holdings, Inc. ("Motus"), and shall convert into Common Stock upon the occurrence of certain events. Please see the Motus Registration Statement filed with the Securities and Exchange Commission on Form S-1 (File No. 333-222441) (the "Registration Statement") for a complete description of the conversion rights.
- [F2]The securities were acquired as consideration for entering into one or more agreements in connection with Company's initial public offering. Please see the Registration Statement for a complete description of the warrant terms and such agreements.